Skip to main content

Table 1 Kinetics data of Gensci059 to extracellular domain of CD47

From: Gentulizumab, a novel anti-CD47 antibody with potent antitumor activity and demonstrates a favorable safety profile

Species

ka (1/Ms)

kd (1/s)

KD (M)

Human CD47

2.49E + 05

5.11E-03

2.05E-08

Cynomolgus CD47

2.70E + 05

3.73E-03

1.38E-08

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us